For decades, discovering a new drug was a painstaking journey of trial and error, often compared to searching for a needle in a haystack. Today, that haystack is being illuminated by the transformative power of Computational Biology and AI, turning a blind search into a precise, data-driven science. This revolution is reshaping medicine at its core, accelerating the journey from a novel...
A new medicine does not reach the market through research alone. Between discovering a promising compound and producing a commercially available therapy lies a long chain of development, testing, formulation, manufacturing, quality control, regulatory work, and supply management. As pharmaceutical and biotechnology companies build increasingly complex pipelines, many are choosing not to develop...
The Active Pharmaceutical Ingredients Market is expanding alongside the global need for medicines, with pharmaceutical manufacturers responding to rising chronic disease prevalence, an aging population, and increasing demand for generic and innovative therapies. The market reached USD 270.5 billion in 2025 and is projected to reach USD 419.0 billion by 2033, registering a 5.6% CAGR from 2026 to...
The Dairy Processing Equipment Market is entering a period of steady expansion as dairy consumption shifts toward processed, convenient, and value-added products.
Market size: USD 14.5 billion in 2025
Projected market size: USD 24.0 billion by 2033
CAGR: 6.4% from 2026 to 2033
Largest equipment segment: Pasteurizers, with 23.3% share in 2025
Leading...
Lipids play a vital role in biological membranes. They provide a barrier for almost all cellular structures and act as dynamic building blocks, enabling certain membrane proteins to function efficiently and facilitating signal transduction. In addition to their involvement in metabolism and energy conversion, lipids are also involved in various developmental processes, such as cell growth and...
The enzyme-linked immunosorbent assay (ELISA) was independently developed in 1971 by Engall and Perlmann and by van Weemen and Schuurs with the aim of avoiding the problems associated with radioimmunoassays. Since then, ELISA has become a widely used method for detecting polyclonal and monoclonal antibodies in biological fluids or culture media.
Offering advantages such as high specificity,...
The global Sterile Injectables CDMO Market was valued at USD 37.8 billion in 2025 and is projected to grow from USD 41.6 billion in 2026 to USD 87.3 billion by 2033, expanding at a CAGR of 11.2% from 2026 to 2033. North America accounted for the largest revenue share of 33.7% in 2025, supported by the presence of leading pharmaceutical manufacturers, strong biologics pipelines, and...
The global Small Molecule Innovator API CDMO market was valued at USD 26.7 billion in 2025 and is projected to grow from USD 28.1 billion in 2026 to USD 43.7 billion by 2033, registering a CAGR of 6.6% from 2026 to 2033. Asia Pacific accounted for the largest 41.9% revenue share in 2025, supported by expanding pharmaceutical manufacturing capabilities, cost-efficient production...
The global Small Molecule Innovator API CDMO market was valued at USD 26.7 billion in 2025 and is projected to grow from USD 28.1 billion in 2026 to USD 43.7 billion by 2033, registering a CAGR of 6.6% from 2026 to 2033. Asia Pacific accounted for the largest 41.9% revenue share in 2025, supported by expanding pharmaceutical manufacturing capabilities, cost-efficient production...
The global drug discovery service market is witnessing rapid growth due to increasing pharmaceutical and biotechnology research activities, rising demand for outsourced drug development services, expanding investments in precision medicine, and continuous advancements in artificial intelligence and genomics. The global drug discovery service market size was valued at USD 15.41 billion...
RNA Therapeutics Market
The global RNA therapeutics market is experiencing remarkable growth due to increasing investments in precision medicine, rapid advancements in RNA-based technologies, and the rising prevalence of chronic and genetic diseases. The global RNA therapeutics market size is valued at USD 20.32 billion in 2025 and is anticipated to grow from USD 22.15...
Germany specialty oxidant market, valued at approximately USD 186.4 million in 2025, is projected to grow at a steady Compound Annual Growth Rate (CAGR) of 3.5%, reaching an estimated USD 254.9 million by 2034. The market's expansion is fueled by Germany's unwavering commitment to environmental stewardship driving the adoption of advanced oxidation processes (AOPs) for micropollutant...